2022, Number 1
Clinical manifestations of herpes virus type 6 in a pediatric patient
Language: Spanish
References: 10
Page: 237-242
PDF size: 331.54 Kb.
ABSTRACT
Herpes virus type 6 belongs to the family of herpes viruses that cause infections in humans. It is characterized by producing liver damage with systemic manifestations in the body. The most frequent form is a mononucleosis syndrome in immune-competent patients. The presentation is highly variable and it is very rare in adolescents. The seventeen years-old patient, had a prolonged febrile syndrome with three months of evolution. He was referred from his health area Fray Benito, municipality of Rafael Freyre, to the Pediatric Hospital Octavio de la Concepción y la Pedraja at Holguín, Cuba. In addition to the above mentioned symptoms, he had pale cutaneous mucosa, general discomfort and a state of prostration. The studies to determine toxoplasmosis, other infections (such as syphilis or HIV), rubella, cytomegalovirus and herpes simplex (ToRCH), conducted at Pedro Kouri Tropical Medicine Institute, diagnosed the virus. It was treated for fourteen days with ganciclovir intravenously, at a rate of 5ml/kg/day every twelve hours, evolving favourably to this day.REFERENCES
Ávila González GI, Erazo Narváez AF, Sánchez Muñoz F, Riascos Montes RA, Anacona C, Dueñas Cuellar RA, et al. Infección por Herpes virus Humano tipo 6 relacionado con manifestaciones dermatológicas y fatiga crónica: serie de casos. Univ Salud. 2021[citado 02/08/2021]; 23(1): 64-70. Disponible en:https://revistas.udenar.edu.co/index.php/usalud/article/view/4987/6933
Estrada Pereira GA, Martínez Chaswell DR, Pullés Fernández MC, Sarmiento Casamayor A. Diagnóstico clínico y citopatológico del virus del herpes simple bucal en pacientes con trasplante de riñón. Medisur. 2019[citado 20/02/2021];17(1). Disponible en:http://www.medisur.sld.cu/index.php/medisur/article/view/3816
Álvarez S, Delama I, Navajas Galimany L, Eymin G, Ceballos ME, Andino Navarrete R.Infección por virus herpes humano 6 en un paciente inmunocompetente con síndrome DRESS secundario a carbamazepina. Rev Chil Infectol.2016[citado 02/04/2020];33(3):340-345. Disponible en: http://dx.doi.org/10.4067/S0716-10182016000300016